193 related articles for article (PubMed ID: 31486773)
1. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
2. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
3. Microglia in Prion Diseases: Angels or Demons?
Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation in Prion Disease.
Li B; Chen M; Zhu C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
[TBL] [Abstract][Full Text] [Related]
5. The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation.
Shi F; Yang L; Kouadir M; Yang Y; Wang J; Zhou X; Yin X; Zhao D
J Neuroinflammation; 2012 Jul; 9():73. PubMed ID: 22531291
[TBL] [Abstract][Full Text] [Related]
6. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.
Hafner-Bratkovič I; Benčina M; Fitzgerald KA; Golenbock D; Jerala R
Cell Mol Life Sci; 2012 Dec; 69(24):4215-28. PubMed ID: 22926439
[TBL] [Abstract][Full Text] [Related]
8. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
[TBL] [Abstract][Full Text] [Related]
9. A neuroprotective role for microglia in prion diseases.
Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia.
Chang J; Yang L; Kouadir M; Peng Y; Zhang S; Shi F; Zhou X; Yin X; Zhao D
J Mol Neurosci; 2012 Sep; 48(1):248-52. PubMed ID: 22648512
[TBL] [Abstract][Full Text] [Related]
11. Loss of Homeostatic Microglia Signature in Prion Diseases.
Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
[TBL] [Abstract][Full Text] [Related]
12. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
13. Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.
Nuvolone M; Paolucci M; Sorce S; Kana V; Moos R; Matozaki T; Aguzzi A
PLoS One; 2017; 12(5):e0177876. PubMed ID: 28545141
[TBL] [Abstract][Full Text] [Related]
14. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease.
Alibhai J; Diack A; Manson J
Prion; 2017 Nov; 11(6):381-387. PubMed ID: 29023184
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.
Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Angeletti M; Eleuteri AM
Apoptosis; 2010 Nov; 15(11):1322-35. PubMed ID: 20213200
[TBL] [Abstract][Full Text] [Related]
17. Microglial cells in neurodegenerative disorders.
Wojtera M; Sikorska B; Sobow T; Liberski PP
Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
[TBL] [Abstract][Full Text] [Related]
18. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
Roettger Y; Zerr I; Dodel R; Bach JP
PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
[TBL] [Abstract][Full Text] [Related]
19. Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.
Risen SJ; Boland SW; Sharma S; Weisman GM; Shirley PM; Latham AS; Hay AJD; Gilberto VS; Hines AD; Brindley S; Brown JM; McGrath S; Chatterjee A; Nagpal P; Moreno JA
ACS Chem Neurosci; 2024 Apr; 15(7):1533-1547. PubMed ID: 38507813
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells.
Jen HI; Lin ZY; Guo JX; Lee CI
Cells; 2020 Oct; 9(10):. PubMed ID: 33066249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
